ANN NEUROL 润色咨询

ANNALS OF NEUROLOGY

出版年份:1977 年文章数:3715 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:2.4% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2164067, encodeId=deb8216406ee1, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:血管病<br>经验分享:投稿后马上变成under review,两天后变成evaluating recomendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Sat Oct 21 10:10:02 CST 2023, time=2023-10-21, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2131011, encodeId=c3b8213101144, content=投了个letter,目前一个月了,还是在编辑手上,Under Review。不知道啥情况,有知道的道友说一下不?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94c62540847, createdName=1251f664m27暂无昵称, createdTime=Mon May 08 19:11:26 CST 2023, time=2023-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2117137, encodeId=3077211e13723, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享:第二天就Under Review,不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4b8564886, createdName=ms8000001884736215, createdTime=Thu Mar 02 00:09:26 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167952, encodeId=30d5216e95222, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:近几年要求较高,研究质量高可试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c575257301, createdName=147f4ce1m48(暂无昵称), createdTime=Sat Nov 11 08:07:33 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1222860, encodeId=2d4b12228606c, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:neurology<br>经验分享:2021.11月投稿,经历2轮review,2022.5突然acccept了,好激动哦,我真的栓Q编辑和审稿人!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Fri May 27 20:35:17 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105092, encodeId=e789210509267, content=一个月过去了,还是under review,有人同样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787d5616907, createdName=ms1000000413306818, createdTime=Fri Dec 09 16:14:51 CST 2022, time=2022-12-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223750, encodeId=1e561223e5058, content=投稿之后会给所有作者发邮件确认吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Wed Jun 01 01:51:13 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069294, encodeId=deb510692940a, content=在读小硕,最近怀着试一试的心态投了一个neuro-image,杂志效率之高令人惊叹 投稿10-28 Evaluating recommendations 11-3 aecept 11-9.直接接收,实属意外之喜,在投稿jama neurology 和neurology接连被拒后,终于是在这个杂志看到曙光, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62f12466313, createdName=1242a61em70暂无昵称, createdTime=Thu Nov 11 15:46:37 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203579, encodeId=568d12035e972, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:neurology<br>经验分享:请教一下大神,第一次revise后大概多久会得到编辑的回复?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Thu Mar 17 20:45:54 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086756, encodeId=04a21086e560f, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2023-10-21 ms3000000820351175 来自荷兰

    审稿速度:1.0 | 投稿命中率:5.0
    偏重的研究方向:血管病
    经验分享:投稿后马上变成under review,两天后变成evaluating recomendation

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2164067, encodeId=deb8216406ee1, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:血管病<br>经验分享:投稿后马上变成under review,两天后变成evaluating recomendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Sat Oct 21 10:10:02 CST 2023, time=2023-10-21, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2131011, encodeId=c3b8213101144, content=投了个letter,目前一个月了,还是在编辑手上,Under Review。不知道啥情况,有知道的道友说一下不?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94c62540847, createdName=1251f664m27暂无昵称, createdTime=Mon May 08 19:11:26 CST 2023, time=2023-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2117137, encodeId=3077211e13723, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享:第二天就Under Review,不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4b8564886, createdName=ms8000001884736215, createdTime=Thu Mar 02 00:09:26 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167952, encodeId=30d5216e95222, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:近几年要求较高,研究质量高可试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c575257301, createdName=147f4ce1m48(暂无昵称), createdTime=Sat Nov 11 08:07:33 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1222860, encodeId=2d4b12228606c, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:neurology<br>经验分享:2021.11月投稿,经历2轮review,2022.5突然acccept了,好激动哦,我真的栓Q编辑和审稿人!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Fri May 27 20:35:17 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105092, encodeId=e789210509267, content=一个月过去了,还是under review,有人同样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787d5616907, createdName=ms1000000413306818, createdTime=Fri Dec 09 16:14:51 CST 2022, time=2022-12-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223750, encodeId=1e561223e5058, content=投稿之后会给所有作者发邮件确认吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Wed Jun 01 01:51:13 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069294, encodeId=deb510692940a, content=在读小硕,最近怀着试一试的心态投了一个neuro-image,杂志效率之高令人惊叹 投稿10-28 Evaluating recommendations 11-3 aecept 11-9.直接接收,实属意外之喜,在投稿jama neurology 和neurology接连被拒后,终于是在这个杂志看到曙光, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62f12466313, createdName=1242a61em70暂无昵称, createdTime=Thu Nov 11 15:46:37 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203579, encodeId=568d12035e972, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:neurology<br>经验分享:请教一下大神,第一次revise后大概多久会得到编辑的回复?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Thu Mar 17 20:45:54 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086756, encodeId=04a21086e560f, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2023-05-08 1251f664m27暂无昵称 来自山东省

    投了个letter,目前一个月了,还是在编辑手上,Under Review。不知道啥情况,有知道的道友说一下不?

    9

    展开9条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2164067, encodeId=deb8216406ee1, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:血管病<br>经验分享:投稿后马上变成under review,两天后变成evaluating recomendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Sat Oct 21 10:10:02 CST 2023, time=2023-10-21, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2131011, encodeId=c3b8213101144, content=投了个letter,目前一个月了,还是在编辑手上,Under Review。不知道啥情况,有知道的道友说一下不?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94c62540847, createdName=1251f664m27暂无昵称, createdTime=Mon May 08 19:11:26 CST 2023, time=2023-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2117137, encodeId=3077211e13723, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享:第二天就Under Review,不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4b8564886, createdName=ms8000001884736215, createdTime=Thu Mar 02 00:09:26 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167952, encodeId=30d5216e95222, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:近几年要求较高,研究质量高可试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c575257301, createdName=147f4ce1m48(暂无昵称), createdTime=Sat Nov 11 08:07:33 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1222860, encodeId=2d4b12228606c, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:neurology<br>经验分享:2021.11月投稿,经历2轮review,2022.5突然acccept了,好激动哦,我真的栓Q编辑和审稿人!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Fri May 27 20:35:17 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105092, encodeId=e789210509267, content=一个月过去了,还是under review,有人同样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787d5616907, createdName=ms1000000413306818, createdTime=Fri Dec 09 16:14:51 CST 2022, time=2022-12-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223750, encodeId=1e561223e5058, content=投稿之后会给所有作者发邮件确认吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Wed Jun 01 01:51:13 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069294, encodeId=deb510692940a, content=在读小硕,最近怀着试一试的心态投了一个neuro-image,杂志效率之高令人惊叹 投稿10-28 Evaluating recommendations 11-3 aecept 11-9.直接接收,实属意外之喜,在投稿jama neurology 和neurology接连被拒后,终于是在这个杂志看到曙光, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62f12466313, createdName=1242a61em70暂无昵称, createdTime=Thu Nov 11 15:46:37 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203579, encodeId=568d12035e972, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:neurology<br>经验分享:请教一下大神,第一次revise后大概多久会得到编辑的回复?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Thu Mar 17 20:45:54 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086756, encodeId=04a21086e560f, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2023-03-02 ms8000001884736215 来自北京

    审稿速度:2.0 | 投稿命中率:5.0
    经验分享:第二天就Under Review,不知道啥意思

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2164067, encodeId=deb8216406ee1, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:血管病<br>经验分享:投稿后马上变成under review,两天后变成evaluating recomendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Sat Oct 21 10:10:02 CST 2023, time=2023-10-21, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2131011, encodeId=c3b8213101144, content=投了个letter,目前一个月了,还是在编辑手上,Under Review。不知道啥情况,有知道的道友说一下不?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94c62540847, createdName=1251f664m27暂无昵称, createdTime=Mon May 08 19:11:26 CST 2023, time=2023-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2117137, encodeId=3077211e13723, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享:第二天就Under Review,不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4b8564886, createdName=ms8000001884736215, createdTime=Thu Mar 02 00:09:26 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167952, encodeId=30d5216e95222, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:近几年要求较高,研究质量高可试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c575257301, createdName=147f4ce1m48(暂无昵称), createdTime=Sat Nov 11 08:07:33 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1222860, encodeId=2d4b12228606c, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:neurology<br>经验分享:2021.11月投稿,经历2轮review,2022.5突然acccept了,好激动哦,我真的栓Q编辑和审稿人!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Fri May 27 20:35:17 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105092, encodeId=e789210509267, content=一个月过去了,还是under review,有人同样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787d5616907, createdName=ms1000000413306818, createdTime=Fri Dec 09 16:14:51 CST 2022, time=2022-12-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223750, encodeId=1e561223e5058, content=投稿之后会给所有作者发邮件确认吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Wed Jun 01 01:51:13 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069294, encodeId=deb510692940a, content=在读小硕,最近怀着试一试的心态投了一个neuro-image,杂志效率之高令人惊叹 投稿10-28 Evaluating recommendations 11-3 aecept 11-9.直接接收,实属意外之喜,在投稿jama neurology 和neurology接连被拒后,终于是在这个杂志看到曙光, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62f12466313, createdName=1242a61em70暂无昵称, createdTime=Thu Nov 11 15:46:37 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203579, encodeId=568d12035e972, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:neurology<br>经验分享:请教一下大神,第一次revise后大概多久会得到编辑的回复?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Thu Mar 17 20:45:54 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086756, encodeId=04a21086e560f, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2023-11-11 147f4ce1m48(暂无昵称) 来自北京

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享:近几年要求较高,研究质量高可试试

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2164067, encodeId=deb8216406ee1, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:血管病<br>经验分享:投稿后马上变成under review,两天后变成evaluating recomendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Sat Oct 21 10:10:02 CST 2023, time=2023-10-21, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2131011, encodeId=c3b8213101144, content=投了个letter,目前一个月了,还是在编辑手上,Under Review。不知道啥情况,有知道的道友说一下不?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94c62540847, createdName=1251f664m27暂无昵称, createdTime=Mon May 08 19:11:26 CST 2023, time=2023-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2117137, encodeId=3077211e13723, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享:第二天就Under Review,不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4b8564886, createdName=ms8000001884736215, createdTime=Thu Mar 02 00:09:26 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167952, encodeId=30d5216e95222, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:近几年要求较高,研究质量高可试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c575257301, createdName=147f4ce1m48(暂无昵称), createdTime=Sat Nov 11 08:07:33 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1222860, encodeId=2d4b12228606c, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:neurology<br>经验分享:2021.11月投稿,经历2轮review,2022.5突然acccept了,好激动哦,我真的栓Q编辑和审稿人!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Fri May 27 20:35:17 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105092, encodeId=e789210509267, content=一个月过去了,还是under review,有人同样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787d5616907, createdName=ms1000000413306818, createdTime=Fri Dec 09 16:14:51 CST 2022, time=2022-12-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223750, encodeId=1e561223e5058, content=投稿之后会给所有作者发邮件确认吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Wed Jun 01 01:51:13 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069294, encodeId=deb510692940a, content=在读小硕,最近怀着试一试的心态投了一个neuro-image,杂志效率之高令人惊叹 投稿10-28 Evaluating recommendations 11-3 aecept 11-9.直接接收,实属意外之喜,在投稿jama neurology 和neurology接连被拒后,终于是在这个杂志看到曙光, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62f12466313, createdName=1242a61em70暂无昵称, createdTime=Thu Nov 11 15:46:37 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203579, encodeId=568d12035e972, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:neurology<br>经验分享:请教一下大神,第一次revise后大概多久会得到编辑的回复?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Thu Mar 17 20:45:54 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086756, encodeId=04a21086e560f, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2022-05-27 12588598m48暂无昵称

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:neurology
    经验分享:2021.11月投稿,经历2轮review,2022.5突然acccept了,好激动哦,我真的栓Q编辑和审稿人!

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2164067, encodeId=deb8216406ee1, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:血管病<br>经验分享:投稿后马上变成under review,两天后变成evaluating recomendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Sat Oct 21 10:10:02 CST 2023, time=2023-10-21, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2131011, encodeId=c3b8213101144, content=投了个letter,目前一个月了,还是在编辑手上,Under Review。不知道啥情况,有知道的道友说一下不?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94c62540847, createdName=1251f664m27暂无昵称, createdTime=Mon May 08 19:11:26 CST 2023, time=2023-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2117137, encodeId=3077211e13723, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享:第二天就Under Review,不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4b8564886, createdName=ms8000001884736215, createdTime=Thu Mar 02 00:09:26 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167952, encodeId=30d5216e95222, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:近几年要求较高,研究质量高可试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c575257301, createdName=147f4ce1m48(暂无昵称), createdTime=Sat Nov 11 08:07:33 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1222860, encodeId=2d4b12228606c, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:neurology<br>经验分享:2021.11月投稿,经历2轮review,2022.5突然acccept了,好激动哦,我真的栓Q编辑和审稿人!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Fri May 27 20:35:17 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105092, encodeId=e789210509267, content=一个月过去了,还是under review,有人同样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787d5616907, createdName=ms1000000413306818, createdTime=Fri Dec 09 16:14:51 CST 2022, time=2022-12-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223750, encodeId=1e561223e5058, content=投稿之后会给所有作者发邮件确认吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Wed Jun 01 01:51:13 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069294, encodeId=deb510692940a, content=在读小硕,最近怀着试一试的心态投了一个neuro-image,杂志效率之高令人惊叹 投稿10-28 Evaluating recommendations 11-3 aecept 11-9.直接接收,实属意外之喜,在投稿jama neurology 和neurology接连被拒后,终于是在这个杂志看到曙光, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62f12466313, createdName=1242a61em70暂无昵称, createdTime=Thu Nov 11 15:46:37 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203579, encodeId=568d12035e972, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:neurology<br>经验分享:请教一下大神,第一次revise后大概多久会得到编辑的回复?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Thu Mar 17 20:45:54 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086756, encodeId=04a21086e560f, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2022-12-09 ms1000000413306818 来自福建省

    一个月过去了,还是under review,有人同样情况的吗

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2164067, encodeId=deb8216406ee1, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:血管病<br>经验分享:投稿后马上变成under review,两天后变成evaluating recomendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Sat Oct 21 10:10:02 CST 2023, time=2023-10-21, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2131011, encodeId=c3b8213101144, content=投了个letter,目前一个月了,还是在编辑手上,Under Review。不知道啥情况,有知道的道友说一下不?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94c62540847, createdName=1251f664m27暂无昵称, createdTime=Mon May 08 19:11:26 CST 2023, time=2023-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2117137, encodeId=3077211e13723, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享:第二天就Under Review,不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4b8564886, createdName=ms8000001884736215, createdTime=Thu Mar 02 00:09:26 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167952, encodeId=30d5216e95222, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:近几年要求较高,研究质量高可试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c575257301, createdName=147f4ce1m48(暂无昵称), createdTime=Sat Nov 11 08:07:33 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1222860, encodeId=2d4b12228606c, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:neurology<br>经验分享:2021.11月投稿,经历2轮review,2022.5突然acccept了,好激动哦,我真的栓Q编辑和审稿人!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Fri May 27 20:35:17 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105092, encodeId=e789210509267, content=一个月过去了,还是under review,有人同样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787d5616907, createdName=ms1000000413306818, createdTime=Fri Dec 09 16:14:51 CST 2022, time=2022-12-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223750, encodeId=1e561223e5058, content=投稿之后会给所有作者发邮件确认吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Wed Jun 01 01:51:13 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069294, encodeId=deb510692940a, content=在读小硕,最近怀着试一试的心态投了一个neuro-image,杂志效率之高令人惊叹 投稿10-28 Evaluating recommendations 11-3 aecept 11-9.直接接收,实属意外之喜,在投稿jama neurology 和neurology接连被拒后,终于是在这个杂志看到曙光, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62f12466313, createdName=1242a61em70暂无昵称, createdTime=Thu Nov 11 15:46:37 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203579, encodeId=568d12035e972, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:neurology<br>经验分享:请教一下大神,第一次revise后大概多久会得到编辑的回复?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Thu Mar 17 20:45:54 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086756, encodeId=04a21086e560f, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2022-06-01 ms6000000601742295

    投稿之后会给所有作者发邮件确认吗?

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2164067, encodeId=deb8216406ee1, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:血管病<br>经验分享:投稿后马上变成under review,两天后变成evaluating recomendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Sat Oct 21 10:10:02 CST 2023, time=2023-10-21, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2131011, encodeId=c3b8213101144, content=投了个letter,目前一个月了,还是在编辑手上,Under Review。不知道啥情况,有知道的道友说一下不?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94c62540847, createdName=1251f664m27暂无昵称, createdTime=Mon May 08 19:11:26 CST 2023, time=2023-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2117137, encodeId=3077211e13723, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享:第二天就Under Review,不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4b8564886, createdName=ms8000001884736215, createdTime=Thu Mar 02 00:09:26 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167952, encodeId=30d5216e95222, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:近几年要求较高,研究质量高可试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c575257301, createdName=147f4ce1m48(暂无昵称), createdTime=Sat Nov 11 08:07:33 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1222860, encodeId=2d4b12228606c, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:neurology<br>经验分享:2021.11月投稿,经历2轮review,2022.5突然acccept了,好激动哦,我真的栓Q编辑和审稿人!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Fri May 27 20:35:17 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105092, encodeId=e789210509267, content=一个月过去了,还是under review,有人同样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787d5616907, createdName=ms1000000413306818, createdTime=Fri Dec 09 16:14:51 CST 2022, time=2022-12-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223750, encodeId=1e561223e5058, content=投稿之后会给所有作者发邮件确认吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Wed Jun 01 01:51:13 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069294, encodeId=deb510692940a, content=在读小硕,最近怀着试一试的心态投了一个neuro-image,杂志效率之高令人惊叹 投稿10-28 Evaluating recommendations 11-3 aecept 11-9.直接接收,实属意外之喜,在投稿jama neurology 和neurology接连被拒后,终于是在这个杂志看到曙光, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62f12466313, createdName=1242a61em70暂无昵称, createdTime=Thu Nov 11 15:46:37 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203579, encodeId=568d12035e972, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:neurology<br>经验分享:请教一下大神,第一次revise后大概多久会得到编辑的回复?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Thu Mar 17 20:45:54 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086756, encodeId=04a21086e560f, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2021-11-11 1242a61em70暂无昵称

    在读小硕,最近怀着试一试的心态投了一个neuro-image,杂志效率之高令人惊叹 投稿10-28 Evaluating recommendations 11-3 aecept 11-9.直接接收,实属意外之喜,在投稿jama neurology 和neurology接连被拒后,终于是在这个杂志看到曙光

    11

    展开11条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2164067, encodeId=deb8216406ee1, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:血管病<br>经验分享:投稿后马上变成under review,两天后变成evaluating recomendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Sat Oct 21 10:10:02 CST 2023, time=2023-10-21, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2131011, encodeId=c3b8213101144, content=投了个letter,目前一个月了,还是在编辑手上,Under Review。不知道啥情况,有知道的道友说一下不?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94c62540847, createdName=1251f664m27暂无昵称, createdTime=Mon May 08 19:11:26 CST 2023, time=2023-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2117137, encodeId=3077211e13723, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享:第二天就Under Review,不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4b8564886, createdName=ms8000001884736215, createdTime=Thu Mar 02 00:09:26 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167952, encodeId=30d5216e95222, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:近几年要求较高,研究质量高可试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c575257301, createdName=147f4ce1m48(暂无昵称), createdTime=Sat Nov 11 08:07:33 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1222860, encodeId=2d4b12228606c, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:neurology<br>经验分享:2021.11月投稿,经历2轮review,2022.5突然acccept了,好激动哦,我真的栓Q编辑和审稿人!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Fri May 27 20:35:17 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105092, encodeId=e789210509267, content=一个月过去了,还是under review,有人同样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787d5616907, createdName=ms1000000413306818, createdTime=Fri Dec 09 16:14:51 CST 2022, time=2022-12-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223750, encodeId=1e561223e5058, content=投稿之后会给所有作者发邮件确认吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Wed Jun 01 01:51:13 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069294, encodeId=deb510692940a, content=在读小硕,最近怀着试一试的心态投了一个neuro-image,杂志效率之高令人惊叹 投稿10-28 Evaluating recommendations 11-3 aecept 11-9.直接接收,实属意外之喜,在投稿jama neurology 和neurology接连被拒后,终于是在这个杂志看到曙光, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62f12466313, createdName=1242a61em70暂无昵称, createdTime=Thu Nov 11 15:46:37 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203579, encodeId=568d12035e972, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:neurology<br>经验分享:请教一下大神,第一次revise后大概多久会得到编辑的回复?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Thu Mar 17 20:45:54 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086756, encodeId=04a21086e560f, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2022-03-17 12588598m48暂无昵称

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:neurology
    经验分享:请教一下大神,第一次revise后大概多久会得到编辑的回复?

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2164067, encodeId=deb8216406ee1, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:血管病<br>经验分享:投稿后马上变成under review,两天后变成evaluating recomendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Sat Oct 21 10:10:02 CST 2023, time=2023-10-21, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2131011, encodeId=c3b8213101144, content=投了个letter,目前一个月了,还是在编辑手上,Under Review。不知道啥情况,有知道的道友说一下不?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94c62540847, createdName=1251f664m27暂无昵称, createdTime=Mon May 08 19:11:26 CST 2023, time=2023-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2117137, encodeId=3077211e13723, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享:第二天就Under Review,不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4b8564886, createdName=ms8000001884736215, createdTime=Thu Mar 02 00:09:26 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167952, encodeId=30d5216e95222, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:近几年要求较高,研究质量高可试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c575257301, createdName=147f4ce1m48(暂无昵称), createdTime=Sat Nov 11 08:07:33 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1222860, encodeId=2d4b12228606c, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:neurology<br>经验分享:2021.11月投稿,经历2轮review,2022.5突然acccept了,好激动哦,我真的栓Q编辑和审稿人!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Fri May 27 20:35:17 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105092, encodeId=e789210509267, content=一个月过去了,还是under review,有人同样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787d5616907, createdName=ms1000000413306818, createdTime=Fri Dec 09 16:14:51 CST 2022, time=2022-12-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223750, encodeId=1e561223e5058, content=投稿之后会给所有作者发邮件确认吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Wed Jun 01 01:51:13 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069294, encodeId=deb510692940a, content=在读小硕,最近怀着试一试的心态投了一个neuro-image,杂志效率之高令人惊叹 投稿10-28 Evaluating recommendations 11-3 aecept 11-9.直接接收,实属意外之喜,在投稿jama neurology 和neurology接连被拒后,终于是在这个杂志看到曙光, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62f12466313, createdName=1242a61em70暂无昵称, createdTime=Thu Nov 11 15:46:37 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203579, encodeId=568d12035e972, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:neurology<br>经验分享:请教一下大神,第一次revise后大概多久会得到编辑的回复?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Thu Mar 17 20:45:54 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086756, encodeId=04a21086e560f, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2021-12-29 桑晒麦拉

    评审和期刊编辑要求我补实验,就一定要补么,不补行不行?

    1

    展开1条回复
共51条页码: 1/6页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分